A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease

INTRODUCTION: Programmed cell death protein 1 (PD-1), an immune checkpoint molecule, has recently been recognized as a predictive and prognostic biomarker in several malignant tumors, but its diagnostic value remains largely unknown. We aimed to investigate the differential diagnostic efficiency of...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chao, Sun, Bing, Xu, Bin, Meng, Xiangying, Li, Lan, Cong, Yang, Liu, Jiannan, Wang, Qian, Xuan, Liang, Song, Qibin, Wu, Shikai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027692/
https://www.ncbi.nlm.nih.gov/pubmed/29983594
http://dx.doi.org/10.2147/CMAR.S160452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027692/
https://www.ncbi.nlm.nih.gov/pubmed/29983594
http://dx.doi.org/10.2147/CMAR.S160452

Ejemplares similares